In our study, patients in the non-response group showed slightly higher levels of BMI and TNF-α and a higher percentage of ileal disease than those in the response group, although the first two differences failed to reach statistical significance.
← all excerpts
A novel role of the splenic volume in Crohn's disease: evaluating the efficacy of infliximab.
1
—
—